Augustine J. Lawlor
Net Worth

Last updated:

What is Augustine J. Lawlor net worth?

The estimated net worth of Mr. Augustine J. Lawlor is at least $5,042,063 as of 26 Jan 2024. He owns shares worth $165,983 as insider and has received compensation worth at least $4,876,080 in Leap Therapeutics, Inc..

What is the salary of Augustine J. Lawlor?

Mr. Augustine J. Lawlor salary is $609,510 per year as Chief Operating Officer in Leap Therapeutics, Inc..

How old is Augustine J. Lawlor?

Mr. Augustine J. Lawlor is 68 years old, born in 1957.

What stocks does Augustine J. Lawlor currently own?

As insider, Mr. Augustine J. Lawlor owns shares in one company:

Company Title Shares Price per share Total value
Leap Therapeutics, Inc. (LPTX) Chief Operating Officer 592,797 $0.28 $165,983

What does Leap Therapeutics, Inc. do?

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Augustine J. Lawlor insider trading

Leap Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Purchase
Warrant (Right to Buy) 571,428 $1.95 $1,114,285
Purchase
Common Stock 571,428 $1.95 $1,114,285
Purchase
Warrant (Right to Buy) 1,057,769 $6.09 $6,436,524
Purchase
Common Stock 1,057,769 $6.09 $6,436,524

Leap Therapeutics key executives

Leap Therapeutics, Inc. executives and other stock owners filed with the SEC: